Intravitreally injected human immunoglobulin attenuates the effects of Staphylococcus aureus culture supernatant in a rabbit model of toxin-mediated endophthalmitis

Archives of Ophthalmology

Volumn 122, Issue 10, 2004, Pages 1499-1506

  Perkins, Stephen L ^a   Han, Dennis P ^a   Burke, Janice M ^a   Schlievert, Patrick M ^b   Wirostko, William J ^a   Tarasewicz, Dariusz G ^a   Skumatz, Christine M B ^a  

^a EYE INSTITUTE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EXOTOXIN; HEMOLYSIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; TOXIC SHOCK SYNDROME TOXIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BIOMICROSCOPY; ENDOPHTHALMITIS; NONHUMAN; OPHTHALMOSCOPY; PRIORITY JOURNAL; RABBIT; SLIT LAMP; STAPHYLOCOCCUS AUREUS; SUPERNATANT; TOXICITY; WESTERN BLOTTING;

ANIMALS; BACTERIAL TOXINS; CULTURE MEDIA; DISEASE MODELS, ANIMAL; ENDOPHTHALMITIS; ENTEROTOXINS; HEMOLYSIN PROTEINS; HUMANS; IMMUNOGLOBULINS; IMMUNOTHERAPY; RABBITS; RETINA; SPHINGOMYELIN PHOSPHODIESTERASE; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; VITREOUS BODY;

EID: 5044224206     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.122.10.1499     Document Type: Article

References (30)

1. Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study: a randomized trial of immediate vitrectomy and intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol. 1995;113:1479-1496.
2. Endophthalmitis Vitrectomy Study Group. Microbiologic factors and visual outcome in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122:830-846.
3. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol. 1996;122:1-17.
4. Kresloff MS, Castellarin AA, Zarbin MA. Endophthalmitis. Surv Ophthalmol. 1998;43:193-224.
5. Waheed S, Ritterband DC, Greenfield DS, Liebmann JM, Seedor JA, Ritch R. New patterns of infecting organisms in late bleb-related endophthalmitis: a ten year review. Eye. 1998;12:910-915.
6. Kunimoto DY, Das T, Sharma S, et al, for the Endophthalmitis Research Group. Microbiologic spectrum and susceptibility of isolates, II: posttraumatic endophthalmitis. Am J Ophthalmol. 1999;128:242-244.
7. Callegan MC, Booth MC, Jett BD, Gilmore MS. Pathogenesis of gram-positive bacterial endophthalmitis. Infect Immun. 1999;67:3348-3356.
8. Jett BD, Jensen HG, Nordquist RE, Gilmore MS. Contribution of the pAD1-encoded cytolysin to the severity of experimental Enterococcus faecalis endophthalmitis. Infect Immun. 1992;60:2445-2452.
9. Stevens SX, Jensen HG, Jett BD, Gilmore MS. A hemolysin-encoding plasmid contributes to bacterial virulence in experimental Enterococcus faecalis endophthalmitis. Invest Ophthalmol Vis Sci. 1992;33:1650-1656.
10. Callegan MC, Jett BD, Hancock LE, Gilmore MS. Role of hemolysin BL in the pathogenesis of extraintestinal Bacillus cereus infection assessed in an endophthalmitis model. Infect Immun. 1999;67:3348-3356.
11. Booth MC, Atkuri RV, Nanda SK, Iandolo JJ, Gilmore MS. Accessory gene regulator controls Staphylococcus aureus virulence in endophthalmitis. Invest Ophthalmol Vis Sci. 1995;36:1828-1836.
12. Booth MC, Cheung AL, Hatter KL, Jett BD, Callegan MC, Gilmore MS, Staphylococcal accessory regulator (sar) in conjunction with agr contributes to Staphylococcus aureus virulence in endophthalmitis. Infect Immun. 1997;65:1550-1556.
13. Supersac G, Piemont Y, Kubina M, Prevost G, Foster TJ. Assessment of the role of gamma-toxin in experimental endophthalmitis using a hlg-deficient mutant of Staphylococcus aureus. Microb Pathog. 1998;24:241-251.
14. Giese MJ, Berliner JA, Riesner A, Wagar EA, Mondino BJ. A comparison of the early inflammatory effects of an agr-/sar- versus a wild type strain of Staphylococcus aureus in a rat model of endophthalmitis. Curr Eye Res. 1999;18:177-185.
15. Dinges MM, Orwin PM, Schlievert PM. Exotoxins of Staphylococcus aureus. Clin Microbiol Rev. 2000;13:16-34.
16. Aguilar HE, Meredith TA, Drews C, Grossniklaus H, Sawant AD, Gardner S. Comparative treatment of experimental Staphylococcus aureus endophthalmitis. Am J Ophthalmol. 1996;121:310-317.
17. Meredith TA, Aguilar HE, Drews C, et al. Intraocular dexamethasone produces a harmful effect on treatment of experimental Staphylococcus aureus endophthalmitis. Trans Am Ophthalmol Soc. 1996;94:241-252.
18. Yoshizumi MO, Lee GC, Equi RA, et al. Timing of dexamethasone treatment in experimental Staphylococcus aureus endophthalmitis. Retina. 1998;18:130-135.
19. Yoshizumi MO, Kashani A, Palmer J, Lee G, Mondino B. High dose intramuscular methylprednisolone in experimental Staphylococcus aureus endophthalmitis. J Ocul Pharmacol Ther. 1999;15:91-96.
20. Jett BD, Jensen HG, Atkuri RV, Gilmore MS. Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin-nonproducing Enterococcus faecalis strains. Invest Ophthalmol Vis Sci. 1995;36:9-15.
21. Bohach GA, Hovde CJ, Handley JP, Schlievert PM. Cross-neutralization of staphylococcal and streptococcal pyrogenic toxins by monoclonal and polyclonal antibodies. Infect Immun. 1988;56:400-404.
22. Schlievert PM. Use of intravenous immunoglobulin in the treatment of staphylococcal and streptococcal toxic shock syndromes and related illnesses. J Allergy Clin Immunol. 2001;108(suppl 4):S107-S110.
23. Gaskin DK, Bohach GA, Schlievert PM, Hovde CJ. Purification of Staphylococcus aureus beta-toxin: comparison of three isoelectric focusing methods. Protein Expr Purif. 1997;9:76-82.
24. McCormick JK, Schlievert PM. Expression, purification, and detection of novel streptococcal superantigens. Methods Mol Biol. 2003;214:33-43.
25. Schlievert PM, Shands KN, Dan BB, Schmid GP, Nishimura RD. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis. 1981;143:509-516.
26. Schlievert PM. Immunochemical assays for toxic shock syndrome toxin-1. Methods Enzymol. 1988;165:339-344.
27. Beecher DJ, Pulido JS, Barney NP, Wong ACL. Extracellular virulence factors in Bacillus cereus endophthalmitis: methods and implication of involvement of hemolysin BL. Infect Immun. 1995;63:632-639.
28. The Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group. MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: the Monoclonal Antibody Cytomegalovirus Retinitis Trial. Arch Ophthalmol. 1997;115:1528-1536.
29. Kimura H, Yasukawa T, Tabata Y, Ogura Y. Drug targeting to choroidal neovascularization. Adv Drug Deliv Rev. 2001;52:79-91.
30. Bohach GA, Fast DJ, Nelson RD, Schlievert PM. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol. 1990;17:251-272.